Suppression of Aurora-A oncogenic potential by c-Myc downregulation

다국어 초록 (Multilingual Abstract)

The abnormality of serine/threonine kinase Aurora-A is seen in many types of cancers. Although in physiological context it has been shown to play a vital role in cellular mitosis, how this oncogene contributes to tumorigenesis remains unclear. Here we demonstrate that Aurora-A overexpression enhances both the expression level and transcriptional activity of c-Myc.
The inhibition of c-Myc expression by RNA interference significantly impaired the oncogenic potential of Aurora-A, resulting in attenuated cellular proliferation and transformation rates as well as fewer centrosomal aberrations. Furthermore, downregulation of c-Myc effectively overcame Aurora-A-induced resistance to cisplatin in esophageal cancer cells. Taken together,our results suggest an important role for c-Myc in mediating the oncogenic activity of Aurora-A, which may in turn allow for future targeting of c-Myc as a potential therapeutic strategy for tumors with Aurora-A overexpression.

참고문헌 (Reference)

1 Dang CV, "c-Myc target genes involved in cell growth, apoptosis, and metabolism" 19 : 1-11, 1999

2 Harrington EA, "VX-680, a potent and selective small-molecule inhibitor of the Aurora kinases, suppresses tumor growth in vivo" 10 : 262-267, 2004

3 Zhou H, "Tumour amplified kinase STK15/BTAK induces centrosome amplification, aneuploidy and transformation" 20 : 189-193, 1998

4 Hauf S, "The small molecule Hesperadin reveals a role for Aurora B in correcting kinetochore-microtubule attachment and in maintaining the spindle assembly checkpoint" 161 : 281-294, 2003

5 Tanaka E, "The clinical significance of Aurora-A/STK15/BTAK expression in human esophageal squamous cell carcinoma" 11 : 1827-1834, 2005

6 Dar AA, "The aurora kinase A regulates GSK-3beta in gastric cancer cells" 28 : 866-875, 2009

7 Hodges LC, "Tamoxifen functions as a molecular agonist inducing cell cycle-associated genes in breast cancer cells" 1 : 300-311, 2003

8 Jain M, "Sustained loss of a neoplastic phenotype by brief inactivation of MYC" 297 : 102-104, 2002

9 Otto T, "Stabilization of N-Myc is a critical function of Aurora A in human neuroblastoma" 15 : 67-78, 2009

10 Marumoto T, "Roles of aurora-A kinase in mitotic entry and G2 checkpoint in mammalian cells" 7 : 1173-1182, 2002

11 Katayama H, "Phosphorylation by aurora kinase A induces Mdm2-mediated destabilization and inhibition of p53" 36 : 55-62, 2004

12 Li D, "Overexpression of oncogenic STK15/BTAK/Aurora A kinase in human pancreatic cancer" 9 : 991-997, 2003

13 Wang X, "Overexpression of aurora kinase A in mouse mammary epithelium induces genetic instability preceding mammary tumor formation" 25 : 7148-7158, 2006

14 Klein A, "Overexpression and amplification of STK15 in human gliomas" 25 : 1789-1794, 2004

15 Jeng YM, "Overexpression and amplification of Aurora-A in hepatocellular carcinoma" 10 : 2065-2071, 2004

16 Dutertre S, "On the role of aurora-A in centrosome function" 21 : 6175-6183, 2002

17 Jazaeri AA, "Molecular determinants of tumor differentiation in papillary serous ovarian carcinoma" 36 : 53-59, 2003

18 Neben K, "Microarray-based screening for molecular markers in medulloblastoma revealed STK15 as independent predictor for survival" 64 : 3103-3111, 2004

19 Slack AD, "MYCN-directed centrosome amplification requires MDM2- mediated suppression of p53 activity in neuroblastoma cells" 67 : 2448-2455, 2007

20 Wang YH, "Knockdown of c-Myc expression by RNAi inhibits MCF-7 breast tumor cells growth in vitro and in vivo" 7 : R220-R228, 2005

21 Yih LH, "Induction of centrosome amplification during arsenite-induced mitotic arrest in CGL-2 cells" 66 : 2098-2106, 2006

22 Ewart-Toland A, "Identification of Stk6/STK15 as a candidate low-penetrance tumor-susceptibility gene in mouse and human" 34 : 403-412, 2003

23 Zhou CQ, "Down-regulation of gamma-synuclein in human esophageal squamous cell carcinoma" 9 : 1900-1903, 2003

24 Schlegel J, "Comparative genomic in situ hybridization of colon carcinomas with replication error" 55 : 6002-6005, 1995

25 Forozan F, "Comparative genomic hybridization analysis of 38 breast cancer cell lines: a basis for interpreting complementary DNA microarray data" 60 : 4519-4525, 2000

26 Fukushima N, "Characterization of gene expression in mucinous cystic neoplasms of the pancreas using oligonucleotide microarrays" 23 : 9042-9051, 2004

27 Jiang Y, "AuroraA overexpression overrides the mitotic spindle checkpoint triggered by nocodazole, a microtubule destabilizer" 22 : 8293-8301, 2003

28 Meraldi P, "Aurora-A overexpression reveals tetraploidization as a major route to centrosome amplification in p53-/- cells" 21 : 483-492, 2002

29 Yang H, "Aurora-A induces cell survival and chemoresistance by activation of Akt through a p53-dependent manner in ovarian cancer cells" 119 : 2304-2312, 2006

30 Liu Q, "Aurora-A abrogation of p53 DNA binding and transactivation activity by phosphorylation of serine 215" 279 : 52175-52182, 2004

31 Ditchfield C, "Aurora B couples chromosome alignment with anaphase by targeting BubR1, Mad2, and Cenp-E to kinetochores" 161 : 267-280, 2003

32 Lassmann S, "Array CGH identifies distinct DNA copy number profiles of oncogenes and tumor suppressor genes in chromosomal- and microsatellite-unstable sporadic colorectal carcinomas" 85 : 293-304, 2007

33 Sen S, "Amplification/overexpression of a mitotic kinase gene in human bladder cancer" 94 : 1320-1329, 2002

34 Kamada K, "Amplification/overexpression of Aurora-A in human gastric carcinoma: potential role in differentiated type gastric carcinogenesis" 12 : 593-599, 2004

35 Anand S, "AURORA-A amplification overrides the mitotic spindle assembly checkpoint, inducing resistance to Taxol" 3 : 51-62, 2003

36 Reznikoff CA, "A molecular genetic model of human bladder cancer pathogenesis" 23 : 571-584, 1996

37 Bischoff JR, "A homologue of Drosophila aurora kinase is oncogenic and amplified in human colorectal cancers" 17 : 3052-3065, 1998